GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dezhan Healthcare Co Ltd (SZSE:000813) » Definitions » Price-to-Free-Cash-Flow

Dezhan Healthcare Co (SZSE:000813) Price-to-Free-Cash-Flow : N/A (As of Jun. 01, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Dezhan Healthcare Co Price-to-Free-Cash-Flow?

As of today (2025-06-01), Dezhan Healthcare Co's share price is ¥3.29. Dezhan Healthcare Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.09. Hence, Dezhan Healthcare Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Dezhan Healthcare Co's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Dezhan Healthcare Co's highest Price-to-Free-Cash-Flow Ratio was 2500.00. The lowest was 7.36. And the median was 71.95.

SZSE:000813's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 23.7
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Dezhan Healthcare Co's Free Cash Flow per Share for the three months ended in Mar. 2025 was ¥-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥-0.09.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -30.30% per year.

During the past 13 years, Dezhan Healthcare Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 123.60% per year. The lowest was -90.00% per year. And the median was 12.20% per year.


Dezhan Healthcare Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Dezhan Healthcare Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dezhan Healthcare Co Price-to-Free-Cash-Flow Chart

Dezhan Healthcare Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.72 - 86.28 - -

Dezhan Healthcare Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dezhan Healthcare Co's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Dezhan Healthcare Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dezhan Healthcare Co's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dezhan Healthcare Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Dezhan Healthcare Co's Price-to-Free-Cash-Flow falls into.


;
;

Dezhan Healthcare Co Price-to-Free-Cash-Flow Calculation

Dezhan Healthcare Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=3.29/-0.094
=N/A

Dezhan Healthcare Co's Share Price of today is ¥3.29.
Dezhan Healthcare Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Dezhan Healthcare Co  (SZSE:000813) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Dezhan Healthcare Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Dezhan Healthcare Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Dezhan Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
No. 235 Yin Chuan Road, Xinjiang, Urumqi, CHN, 830054
Dezhan Healthcare Co Ltd's main business is drug research and development, production, and sales. The company's wholly-owned subsidiary Jialin Pharmaceuticals mainly engages in the research and development, production, and sale of cardiovascular drugs, the drugs being produced and sold including Ale (10mg), Alle (20mg), hydrochloric acid quercetine capsules, Van Le tablets type 1, Van Le tablets.
Executives
Liu Ye Executives
Zhang Yong Director
Gao Li Supervisors
Sun Ji Lu Supervisors
Wang Xiao Ping Director

Dezhan Healthcare Co Headlines

No Headlines